As of 2025-07-12, the Relative Valuation of Harpoon Therapeutics Inc (HARP) is (19.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 23.01 USD, the upside of Harpoon Therapeutics Inc based on Relative Valuation is -186.1%.
The range of the Relative Valuation is (15.05) - (26.91) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 18.9x | 13.6x |
| Forward P/E multiples | 10.6x - 21.5x | 14.2x |
| Fair Price | (15.05) - (26.91) | (19.81) |
| Upside | -165.4% - -216.9% | -186.1% |
| Date | P/E |